Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Depression
- Cardiology
- Sexual Health
- Sleep Medicine and Disorders
- Nuclear Medicine
- Anatomy
- Pharmacology and Therapeutics
- Radiology Cases
Abstract
Citation: Clin Case Rep Int. 2020;4(1):1133.DOI: 10.25107/2638-4558.1133
Graves’ Ophthalmopathy Associated to Idiopathic Orbital Inflammatory Pseudotumor
Salem Bouomrani, Wided Letaïef, Rim Mesfar and Ines Lamloum
Department of Internal Medicine, Military Hospital of Gabes, Tunisia Department of Medicine, University of Sfax, Tunisia Department of Obstetrics and Gynecology, Regional Hospital of Gabes, Tunisia
*Correspondance to: Salem Bouomrani
PDF Full Text Case Report | Open Access
Abstract:
Introduction: Association of orbital inflammatory pseudotumor and Graves’ ophthalmopathy remains exceptional and unusual with only a few sporadic cases reported in the world literature. This situation represents a real challenge for health practitioners. We report the original case of idiopathic orbital inflammatory pseudotumor associated with Graves' ophthalmopathy in elderly patient. Case Presentation: A 62-year-old woman with a history of right idiopathic dacryoadenitis and good outcome under systemic glucosteroids was explored two years later for acute and painful bilateral exophthalmia. Somatic examination noted asymmetrical, non-reducible, and painful bilateral exophthalmos with bilateral upper lid retraction. These signs were more prominent in the left eye. There was also a homogeneous and painless goiter. Biology revealed hyperthyroidism: fT4 at 25.4 pmol/l and TSH at 0.01 μIU/ml. Cervical ultrasound demonstrated moderate, homogeneous, micro nodular, and hyper vascularized goiter. The thyroid immunity demonstrated positive anti-rTSH auto antibodies at 2.5 IU/ml. The diagnosis of Graves' disease complicated by thyroid-associated ophthalmopathy was retained. The patient was treated with methimazole (30 mg/day) and prednisone (1 mg/kg/day) with a favorable outcome. Conclusion: As rare as it is, this unusual association deserves to be known by all health practitioners to avoid diagnostic delays and improve the prognosis that may be reserved, especially for Graves' ophthalmopathy.
Keywords:
Graves’ ophthalmopathy; Idiopathic orbital inflammatory pseudotumor; Thyroidassociated ophthalmopathy; Graves’ disease; Orbital pseudotumor; Dacryoadenitis
Cite the Article:
Bouomrani S, Letaïef W, Mesfar R, Lamloum I. Graves’ Ophthalmopathy Associated to Idiopathic Orbital Inflammatory Pseudotumor. Clin Case Rep Int. 2020; 4: 1133.